Rapport Therapeutics, Inc. Common Stock

RAPPNASDAQHealthcare● Active

$36.49

+$0.39(+1.08%)

Market Cap$1.3B

P/E Ratio—

52W High$42.269

52W Low$10.505

Avg Volume341K

Open$36.76

Beta0.98

Insider Trades Ownership Employees

Rapport Therapeutics, Inc. Common Stock（RAPP）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · RAPP · 截至 2026年6月8日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.07

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 6%仅显示有效交易 · 排除RSU归属94% Sell ↓

Rapport Therapeutics, Inc. Common Stock内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

RAPP 季度内部人买卖趋势

RAPP 内幕交易卖出 · RAPP 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

1.1M534K0

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · RAPP CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

RAPP 高管卖出股份 · RAPP 董事内幕交易 · SEC Form 4申报

显示最近 75 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
May 26, 2026	Third Rock Ventures V, L.P. 10 percent owner	Sale	18,572	$40.05	$744K	6,280,525	Form 4
May 11, 2026	Third Rock Ventures V, L.P. 10 percent owner	Sale	133,618	$40.24	$5.38M⚡	6,299,097	Form 4
May 7, 2026	Third Rock Ventures V, L.P. 10 percent owner	Sale	271,495	$40.12	$10.89M⚡	6,437,733	Form 4
May 8, 2026	Third Rock Ventures V, L.P. 10 percent owner	Sale	5,018	$40.31	$202K	6,432,715	Form 4
Apr 17, 2026	Third Rock Ventures V, L.P. 10 percent owner	Sale	426,005	$40.32	$17.18M⚡	6,709,228	Form 4
Apr 17, 2026	Yeleswaram Krishnaswamy Chief Development Officer	Sale	20,225	$39.99	$809K	246,426	Form 4
Apr 10, 2026	Yeleswaram Krishnaswamy Chief Development Officer	Sale	500	$34.98	$17K	286,016	Form 4
Apr 13, 2026	Yeleswaram Krishnaswamy Chief Development Officer	Sale	9,165	$34.97	$321K	276,851	Form 4
Apr 14, 2026	Yeleswaram Krishnaswamy Chief Development Officer	Sale	10,200	$35.08	$358K	266,651	Form 4
Apr 8, 2026	Yeleswaram Krishnaswamy Chief Development Officer	Sale	360	$34.90	$13K	286,516	Form 4
Mar 30, 2026	Gault Cheryl COO	Sale	7,161	$28.04	$201K	162,753	Form 4
Mar 30, 2026	Gault Cheryl COO	Sale	2,839	$28.55	$81K	159,914	Form 4
Mar 25, 2026	Yeleswaram Krishnaswamy Chief Development Officer	Sale	10,115	$29.99	$303K	286,876	Form 4
Mar 5, 2026	Gault Cheryl COO	Sale	2,014	$28.93	$58K	169,914	Form 4
Feb 18, 2026	Ceesay Abraham CEO · Director	Sale	3,552	$29.05	$103K	558,528	Form 4
Feb 18, 2026	Ceesay Abraham CEO · Director	Sale	2,281	$29.80	$68K	556,247	Form 4
Feb 18, 2026	Ceesay Abraham CEO · Director	Sale	2,983	$29.04	$87K	22,829	Form 4
Feb 18, 2026	Ceesay Abraham CEO · Director	Sale	2,100	$29.80	$63K	20,729	Form 4
Feb 17, 2026	Bredt David Chief Scientific Officer	Sale	900	$28.02	$25K	394,675	Form 4
Feb 19, 2026	Bredt David Chief Scientific Officer	Option	6,000	$1.80	$11K	393,075	Form 4
Feb 17, 2026	Bredt David Chief Scientific Officer	Sale	5,400	$28.95	$156K	389,275	Form 4
Feb 17, 2026	Bredt David Chief Scientific Officer	Sale	2,200	$29.59	$65K	387,075	Form 4
Jan 20, 2026	Ceesay Abraham CEO · Director	Sale	5,833	$26.12	$152K	562,080	Form 4
Jan 20, 2026	Ceesay Abraham CEO · Director	Sale	5,083	$26.11	$133K	25,812	Form 4
Jan 15, 2026	Bredt David Chief Scientific Officer	Sale	8,300	$26.83	$223K	395,775	Form 4

Third Rock Ventures V, L.P.

10 percent owner

Sale

日期

May 26

股数

18,572

均价

$40.05

总金额

$744K

View Form 4 on SEC.gov

Third Rock Ventures V, L.P.

10 percent owner

Sale

日期

May 11

股数

133,618

均价

$40.24

总金额

$5.38M ⚡

View Form 4 on SEC.gov

Third Rock Ventures V, L.P.

10 percent owner

Sale

日期

May 7

股数

271,495

均价

$40.12

总金额

$10.89M ⚡

View Form 4 on SEC.gov

Third Rock Ventures V, L.P.

10 percent owner

Sale

日期

May 8

股数

5,018

均价

$40.31

总金额

$202K

View Form 4 on SEC.gov

Third Rock Ventures V, L.P.

10 percent owner

Sale

日期

Apr 17

股数

426,005

均价

$40.32

总金额

$17.18M ⚡

View Form 4 on SEC.gov

Yeleswaram Krishnaswamy

Chief Development Officer

Sale

日期

Apr 17

股数

20,225

均价

$39.99

总金额

$809K

View Form 4 on SEC.gov

Yeleswaram Krishnaswamy

Chief Development Officer

Sale

日期

Apr 10

股数

500

均价

$34.98

总金额

$17K

View Form 4 on SEC.gov

Yeleswaram Krishnaswamy

Chief Development Officer

Sale

日期

Apr 13

股数

9,165

均价

$34.97

总金额

$321K

View Form 4 on SEC.gov

Yeleswaram Krishnaswamy

Chief Development Officer

Sale

日期

Apr 14

股数

10,200

均价

$35.08

总金额

$358K

View Form 4 on SEC.gov

Yeleswaram Krishnaswamy

Chief Development Officer

Sale

日期

Apr 8

股数

360

均价

$34.90

总金额

$13K

View Form 4 on SEC.gov

Gault Cheryl

COO

Sale

日期

Mar 30

股数

7,161

均价

$28.04

总金额

$201K

View Form 4 on SEC.gov

Gault Cheryl

COO

Sale

日期

Mar 30

股数

2,839

均价

$28.55

总金额

$81K

View Form 4 on SEC.gov

Yeleswaram Krishnaswamy

Chief Development Officer

Sale

日期

Mar 25

股数

10,115

均价

$29.99

总金额

$303K

View Form 4 on SEC.gov

Gault Cheryl

COO

Sale

日期

Mar 5

股数

2,014

均价

$28.93

总金额

$58K

View Form 4 on SEC.gov

Ceesay Abraham

CEO · Director

Sale

日期

Feb 18

股数

3,552

均价

$29.05

总金额

$103K

View Form 4 on SEC.gov

Ceesay Abraham

CEO · Director

Sale

日期

Feb 18

股数

2,281

均价

$29.80

总金额

$68K

View Form 4 on SEC.gov

Ceesay Abraham

CEO · Director

Sale

日期

Feb 18

股数

2,983

均价

$29.04

总金额

$87K

View Form 4 on SEC.gov

Ceesay Abraham

CEO · Director

Sale

日期

Feb 18

股数

2,100

均价

$29.80

总金额

$63K

View Form 4 on SEC.gov

Bredt David

Chief Scientific Officer

Sale

日期

Feb 17

股数

900

均价

$28.02

总金额

$25K

View Form 4 on SEC.gov

Bredt David

Chief Scientific Officer

Option

日期

Feb 19

股数

6,000

均价

$1.80

总金额

$11K

View Form 4 on SEC.gov

Bredt David

Chief Scientific Officer

Sale

日期

Feb 17

股数

5,400

均价

$28.95

总金额

$156K

View Form 4 on SEC.gov

Bredt David

Chief Scientific Officer

Sale

日期

Feb 17

股数

2,200

均价

$29.59

总金额

$65K

View Form 4 on SEC.gov

Ceesay Abraham

CEO · Director

Sale

日期

Jan 20

股数

5,833

均价

$26.12

总金额

$152K

View Form 4 on SEC.gov

Ceesay Abraham

CEO · Director

Sale

日期

Jan 20

股数

5,083

均价

$26.11

总金额

$133K

View Form 4 on SEC.gov

Bredt David

Chief Scientific Officer

Sale

日期

Jan 15

股数

8,300

均价

$26.83

总金额

$223K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 3

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 RAPP 内幕交易

RAPP 内幕交易

Rapport Therapeutics, Inc. Common Stock（RAPP）内幕交易数据来源于公司内部人（包括Ceesay Abraham (CEO · Director), Bredt David (Chief Scientific Officer), Yeleswaram Krishnaswamy (Chief Development Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。RAPP内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Rapport Therapeutics, Inc. Common Stock机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

RAPP 内幕交易 · 5个问题

Rapport Therapeutics, Inc. Common Stock（RAPP）的内部人包括高管和董事，如Ceesay Abraham (CEO · Director), Bredt David (Chief Scientific Officer), Yeleswaram Krishnaswamy (Chief Development Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

RAPP 董事内幕交易RAPP 内部人名单Rapport Therapeutics, Inc. Common Stock 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026